prikaz prve stranice dokumenta Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
  Download
PDF 452.67 KB
Professional paper - Professional paper
Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
Pharmacological Research, 158 (2020); 104891. https://doi.org/10.1016/j.phrs.2020.104891
Banach, Maciej; Penson, Peter E.; Fras, Zlatko; Vrablik, Michal; Pella, Daniel; Reiner, Željko; Nabavi, Seyed Mohammad; Sahebkar, Amirhossein; Kayikcioglu, Meral; Daccord, Magdalena

Linked objects
COVID-19 | Virtual collection

Institutional repository: Dr Med - University of Zagreb School of Medicine Digital Repository

Cite this document

Banach, M., Penson, P. E., Fras, Z., Vrablik, M., Pella, D., Reiner, Ž. ... Daccord, M. (2020). Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacological Research, 158.. doi: 10.1016/j.phrs.2020.104891

Banach, Maciej, et al. "Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic." Pharmacological Research, vol. 158, 2020. https://doi.org/10.1016/j.phrs.2020.104891

Banach, Maciej, Peter E. Penson, Zlatko Fras, Michal Vrablik, Daniel Pella, Željko Reiner, Seyed Mohammad Nabavi, Amirhossein Sahebkar, Meral Kayikcioglu and Magdalena Daccord. "Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic." Pharmacological Research 158 (2020). https://doi.org/10.1016/j.phrs.2020.104891

Banach, M., et al. (2020) 'Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic', Pharmacological Research, 158. doi: 10.1016/j.phrs.2020.104891

Banach M, Penson PE, Fras Z, Vrablik M, Pella D, Reiner Ž, and sur.. Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic. Pharmacological Research [Internet]. 2020 August [cited 2024 December 25];158. doi: 10.1016/j.phrs.2020.104891

M. Banach, et al., "Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic", Pharmacological Research, vol. 158, August 2020. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:105:602195. [Accessed: 25 December 2024]

Metadata
Title (english)Brief recommendations on the management of adult patients with familial hypercholesterolemia during the COVID-19 pandemic
AuthorMaciej Banach
AuthorPeter E. Penson
AuthorZlatko Fras
AuthorMichal Vrablik
AuthorDaniel Pella
AuthorŽeljko Reiner
AuthorSeyed Mohammad Nabavi
AuthorAmirhossein Sahebkar
AuthorMeral Kayikcioglu
AuthorMagdalena Daccord
Author's institutionUniversity of Zagreb
School of Medicine
(Department of Internal Medicine)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Internal Medicine
Abstract (english)
Individuals with Familial Hypercholesterolaemia (FH) are at very high risk of cardiovascular disease, which is associated with poor outcomes from coronavirus infections. COVID-19 puts strain on healthcare systems and may impair access to routine FH services. On behalf of the International Lipid Expert Panel (ILEP) and the European FH Patient Network (FH Europe), we present brief recommendations on the management of adult patients with FH during the COVID-19 pandemic. We discuss the implications of COVID-19 infections for FH patients, the importance of continuing lipid-lowering therapy where possible, issues relating to safety monitoring and service delivery. We summarise the evidence for additional benefits of statins and other lipid-lowering drugs during viral infections. The recommendations do not override in any way the individual responsibility of physicians to make appropriate and accurate decisions taking into account the condition of a given patient and the doses, rules, and regulations applicable to drugs and devices at the time of their prescription/use.
Keywords (english)
Languageenglish
Publication typeProfessional paper - Professional paper
Publication statusPublished
Peer reviewPeer review
Publication versionPublished version
Journal titlePharmacological Research
Numberingvol. 158, 104891
p-ISSN1043-6618
e-ISSN1096-1186
DOIhttps://doi.org/10.1016/j.phrs.2020.104891
URN:NBNurn:nbn:hr:105:602195
Publication2020-08
Document URLhttps://linkinghub.elsevier.com/retrieve/pii/S1043661820311993
Type of resourceText
Access conditionsOpen access
Terms of useLicence In copyright icon
Created on2021-05-24 08:50:11